chronic hypertension

From Aaushi
Jump to navigation Jump to search

Classification

Etiology

Epidemiology

Pathology

Clinical manifestations

  • see hypertension
  • patients are generally asymptomatic
  • a single blood pressure reading is inadequate; multiple measurements are needed (5-6); combining home BP measurement with office-based measurements improves assessment[46]

Laboratory

Diagnostic procedures

Radiology

Complications

* treatment of stage 1 hypertension (BP=140-159/90-99 mm Hg) reduces cardiovascular risk & mortality (RR=0.7-0.8)[84]

Management

Guidelines from Joint National Committee on High Blood Pressure

* Joint National Committee recommends thiazide diuretic as preferred 1st line agent. A second agent is selected in accord with comormid conditions.[16]

* diuretic 1st line[147]

* USPSTF recommends a thiazide, calcium channel blocker, ACE inhibitor or ARB 1st line in non-black patients

* USPSTF recommends a thiazide or calcium channel blocker as 1st line in black patients

* 23-year mortality same for ACE-inhibitor, calcium channel blocker, diuretic[162]

# most patients need at least 2 agents to control hypertension[11][16]; single pill once a day improves compliance[71]

Notes

More general terms

More specific terms

Additional terms

References

  1. Harrison's Principles of Internal Medicine, 13th ed. Companion Handbook, Isselbacher et al (eds), McGraw-Hill Inc. NY, 1995, pg 829-39, 340-346
  2. 2.0 2.1 Yusuf S et al for the ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008, 358:1547 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18378520
  3. Manual of Medical Therapeutics, 28th ed, Ewald & McKenzie (eds), Little, Brown & Co, Boston, 1995, pg 65-84
  4. 4.00 4.01 4.02 4.03 4.04 4.05 4.06 4.07 4.08 4.09 4.10 4.11 4.12 4.13 4.14 4.15 4.16 4.17 4.18 4.19 4.20 4.21 4.22 4.23 4.24 4.25 4.26 Medical Knowledge Self Assessment Program (MKSAP) 11, 15, 16, 17, 18, 19. American College of Physicians, Philadelphia 1998, 2009, 2012, 2015, 2018, 2021.
    Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022
  5. 5.0 5.1 Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 220-221
  6. 6.0 6.1 Journal Watch 21(3):21, 2001 Mogensen et al Randomised controlled trial of dual blockade of renin- angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ 321:1440, 2000 PMID: https://www.ncbi.nlm.nih.gov/pubmed/11110735
    Phillips CO, Kashani A, Ko DK, Francis G, Krumholz HM. Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials. Arch Intern Med. 2007 Oct 8;167(18):1930-6. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/17923591
  7. Journal Watch 22(8):61, 2002 Oliveria SA et al Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 162:413, 2002 PMID: https://www.ncbi.nlm.nih.gov/pubmed/11863473
  8. Journal Watch 22(8):61, 2002 Boutitie F et al J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data. Ann Intern Med 136:438, 2002 PMID: https://www.ncbi.nlm.nih.gov/pubmed/11900496
  9. 9.0 9.1 9.2 9.3 9.4 Geriatrics Review Syllabus, American Geriatrics Society, 5th edition, 2002-2004; 7th edition 2010
  10. Prescriber's Letter 10(1):1 2003
  11. 11.0 11.1 11.2 Prescriber's Letter 10(4):19 2003
  12. Journal Watch 24(1):5, 2004 Chobanian AV et al The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560, 2003 PMID: https://www.ncbi.nlm.nih.gov/pubmed/12748199
  13. Chobanian AV et al Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42:1206, 2003 PMID: https://www.ncbi.nlm.nih.gov/pubmed/14656957
  14. 14.0 14.1 14.2 Journal Watch 24(6):50, 2004 Birtwhistle RV et al Randomised equivalence trial comparing three month and six month follow up of patients with hypertension by family practitioners. BMJ 328:204, 2004 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/14726370 <Internet> http://bmj.bmjjournals.com/cgi/content/full/328/7433/204
  15. Malinski MK, Sesso HD, Lopez-Jimenez F, Buring JE, Gaziano JM. Alcohol consumption and cardiovascular disease mortality in hypertensive men. Arch Intern Med. 2004 Mar 22;164(6):623-8. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15037490
  16. 16.0 16.1 16.2 16.3 Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Hypertension. 2003 Dec;42(6):1206-52. Epub 2003 Dec 01 PMID: https://www.ncbi.nlm.nih.gov/pubmed/14656957
  17. Journal Watch 23(10):78, 2003 Berl T et al Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Ann Intern Med 138(Apr 1):542, 2003 PMID: https://www.ncbi.nlm.nih.gov/pubmed/12667024
    Snow V et al The Evidence Base for Tight Blood Pressure Control in the Management of Type 2 Diabetes Mellitus Ann Intern Med 138:587, 2003 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/12667031 <Internet> http://www.annals.org/issues/v138n7/full/200304010-00017.html
    Vijan S & Hayward RA Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care. Ann Intern Med 138:593, 2003 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/12667032 <Internet> http://www.annals.org/issues/v138n7/full/200304010-00018.html
  18. 18.0 18.1 Journal Watch 25(1):1, 2005 Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlof B; LIFE Study Investigators. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA. 2004 Nov 17;292(19):2343-9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15547161
    Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris K, Aurup P, Dahlof B. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA. 2004 Nov 17;292(19):2350-6. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15547162
  19. 19.0 19.1 Roumie CK+L et al, Improving blood pressure control through provider education, provider allerts, and patient education: A cluster randomized trial. Ann Intern Med 2006, 145:165 PMID: https://www.ncbi.nlm.nih.gov/pubmed/16880458
  20. 20.0 20.1 Whelton SP, Hyre AD, Pedersen B, Yi Y, Whelton PK, He J. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens. 2005 Mar;23(3):475-81. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15716684
  21. 21.0 21.1 Tabara Y, American Heart Association Conference, Chicago, 2004
  22. 22.0 22.1 Stewart KJ, Bacher AC, Turner KL Effect of exercise on blood pressure in older persons: a randomized controlled trial Archives of Internal Medicine 165:756, 2005 PMID: https://www.ncbi.nlm.nih.gov/pubmed/15824294
  23. 23.0 23.1 Elliott P, Stamler J, Dyer AR, Appel L, Dennis B, Kesteloot H, Ueshima H, Okayama A, Chan Q, Garside DB, Zhou B. Association between protein intake and blood pressure: the INTERMAP Study. Arch Intern Med. 2006 Jan 9;166(1):79-87. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16401814
  24. 24.0 24.1 24.2 24.3 Elliot WJ and Meyer PM Incident diabetes in clinical trials of antihypertensive drugs: A network meta-analysis. Lancet 2007, 369:201 PMID: https://www.ncbi.nlm.nih.gov/pubmed/17240286
  25. 25.0 25.1 Khan N, McAlister FA. Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. CMAJ. 2006 Jun 6;174(12):1737-42. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16754904
  26. 26.0 26.1 Welty FK, Effect of soy nuts on blood pressure and lipie levels in hypertensive, prehypertensive, and normotensive postmenopausal women. Arch Intern Med 2007, 167:1060 PMID: https://www.ncbi.nlm.nih.gov/pubmed/17533209
  27. 27.0 27.1 Prescriber's Letter 14(8): 2007 CHART: AHA Blood Pressure Goals and Treatments Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=230801&pb=PRL (subscription needed) http://www.prescribersletter.com
  28. 28.0 28.1 Wong ND et al, Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004. Arch Intern Med 2007, 167:2431 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18071164
  29. Prescriber's Letter 15(6): 2008 Resistant Hypertension Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=240611&pb=PRL (subscription needed) http://www.prescribersletter.com
  30. 30.0 30.1 Turnball F et al, for the Blood Pressure Lowering Treatment Trialists' Collaboration Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: Meta-analysis of randomised trials. BMJ 2008, 336:1121 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18480116
  31. 31.0 31.1 31.2 Krum H et al. Catheter-based renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-of-principle cohort study. Lancet 2009 Mar 30; [e-pub ahead of print] <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/19332353 <Internet> http://dx.doi.org/10.1016/S0140-6736(09)60566-3
    Doumas M and Douma S. Interventional management of resistant hypertension. Lancet 2009 Mar 30; <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/19332354 <Internet> http://dx.doi.org/10.1016/S0140-6736(09)60624-3
    Symplicity HTN-2 Investigators Renal sympathetic denervation in patients with treatment- resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010 Dec 4; 376:1903 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/21093036 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)62039-9/fulltext
    Doumas M, Douma S. Renal sympathetic denervation: the jury is still out. Lancet 2010 Dec 4; 376:1878 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21093037
    Brandt MC et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol 2012 Mar 6; 59:901. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22381425
    Zile MR and Little WC. Effects of autonomic modulation: More than just blood pressure. J Am Coll Cardiol 2012 Mar 6; 59:910. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22381426
    Krum H et al. Percutaneous renal denervation in patients with treatment- resistant hypertension: Final 3-year report of the Symplicity HTN-1 study. Lancet 2013 Nov 7 PMID: https://www.ncbi.nlm.nih.gov/pubmed/24210779
    ClinicalTrials.gov Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3) http://clinicaltrials.gov/ct2/show/record/NCT01418261
    Meditronic News Release. Jan 9, 2014 Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint. http://newsroom.medtronic.com/phoenix.zhtml?c=251324&p=irol-newsArticle&ID=1889335&highlight=
  32. 32.0 32.1 32.2 Law MR et al
    Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009 May 19; 338:b1665 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/19454737 <Internet> http://dx.doi.org/10.1136/bmj.b1665
  33. Verdecchia P et al Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): An open-label randomised trial. Lancet 2009 Aug 15; 374:525. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19683638
  34. 34.0 34.1 Pimenta E et al Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: Results from a randomized trial. Hypertension 2009 Sep; 54:475 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19620517
  35. 35.0 35.1 Prescriber's Letter 16(12): 2009 Dosing Antihypertensive Meds in Kids CHART: Dosing Antihypertensive Meds in Kids GUIDELINES: Diagnosis and Treatment of Hypertension in Children and Adolescents (NIH) Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=251211&pb=PRL (subscription needed) http://www.prescribersletter.com
  36. 36.0 36.1 Chen L et al Reducing Consumption of Sugar-Sweetened Beverages Is Associated With Reduced Blood Pressure. A Prospective Study Among United States Adults Circulation. 2010, Published online May 24, 2010 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/20497980 <Internet> http://circ.ahajournals.org/cgi/content/abstract/CIRCULATIONAHA.109.911164v1
  37. 37.0 37.1 37.2 37.3 McManus RJ et al, Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial The Lancet, Early Online Publication, 8 July 2010 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20619448 doi:10.1016/S0140-6736(10)60964-6 http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)60964-6/fulltext
    Ogedegbe G Self-titration for treatment of uncomplicated hypertension The Lancet, Early Online Publication, 8 July 2010 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20619449 doi:10.1016/S0140-6736(10)61050-1 http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)61050-1/fulltext
  38. 38.0 38.1 38.2 38.3 Prescriber's Letter 17(10): 2010 COMMENTARY: Combination Therapy for Hypertension CHART: Antihypertensive Combinations PATIENT HANDOUT: Blood Pressure Medications and You PATIENT HANDOUT SPANISH VERSION: Sus Medicamentos Para La Presin Arterial GUIDELINES: Combination Therapy in Hypertension Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=261001&pb=PRL (subscription needed) http://www.prescribersletter.com
  39. 39.0 39.1 39.2 39.3 39.4 Turner ST et al Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension. Am J Hypertens 2010 Sep; 23:1014 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20725057
    Alderman MH et al. Pressor responses to antihypertensive drug types. Am J Hypertens 2010 Sep; 23:1031 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20725055
    Gupta AK et al on behalf of ASCOT investigators. Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT trial. Am J Hypertens 2010 Sep; 23:1023 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20725056
    Brown MJ. Heterogeneity of blood pressure response to therapy. Am J Hypertens 2010 Sep; 23:926. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20733564
    Furberg CD. Renin-guided treatment of hypertension: Time for action. Am J Hypertens 2010 Sep; 23:929. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20733565
  40. 40.0 40.1 40.2 40.3 Prescriber's Letter 17(12): 2010 COMMENTARY: Hypertension Treatment in African American Patients Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=261210&pb=PRL (subscription needed) http://www.prescribersletter.com
  41. 41.0 41.1 Brown MJ et al Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial Lancet. 2011 Jan 22;377(9762):312-20. Epub 2011 Jan 12. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/21236483 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)62003-X/fulltext
  42. 42.0 42.1 Houston TK et al Culturally appropriate storytelling to improve blood pressure: A randomized trial. Ann Intern Med 2011 Jan 18; 154:77. PMID: https://www.ncbi.nlm.nih.gov/pubmed/21242364
  43. 43.0 43.1 Serumaga B et al. Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: Interrupted time series study. BMJ 2011 Jan 25; 342:d108 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21266440
  44. 44.0 44.1 Prescriber's Letter 18(3): 2011 COMMENTARY: Thiazides for Hypertension CHART: Comparison of Commonly Used Diuretics Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=270304&pb=PRL (subscription needed) http://www.prescribersletter.com
  45. Aronow WS et al, ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents J Am Coll Cardiol. 2011 Apr 15. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/21524875 <Internet> http://content.onlinejacc.org/cgi/reprint/j.jacc.2011.01.008v1.pdf
  46. 46.0 46.1 46.2 Powers BJ et al Measuring Blood Pressure for Decision Making and Quality Reporting: Where and How Many Measures? Annals of Internal Medicine: June 20, 2011 154(12):781-788 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/21690592 <Internet> http://www.annals.org/content/154/12/781.full.pdf+html
    Appel LJ et al Improving the Measurement of Blood Pressure: Is It Time for Regulated Standards? Annals of Internal Medicine: June 20, 2011 154(12):838-39 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/21690599 <Internet> http://www.annals.org/content/154/12/838.extract
  47. 47.0 47.1 Rosenfeldt F et al Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure. Biofactors. 2003;18(1-4):91-100. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/14695924
  48. 48.0 48.1 48.2 48.3 48.4 48.5 48.6 48.7 48.8 Geriatric Review Syllabus, 7th edition Parada JT et al (eds) American Geriatrics Society, 2010
    Geriatric Review Syllabus, 8th edition (GRS8) Durso SC and Sullivan GN (eds) American Geriatrics Society, 2013
    Geriatric Review Syllabus, 9th edition (GRS9) Medinal-Walpole A, Pacala JT, Porter JF (eds) American Geriatrics Society, 2016
    Geriatric Review Syllabus, 10th edition (GRS10) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2019
  49. 49.0 49.1 Cappuccio FP et al, Gender-specific associations of short sleep duration with prevalent and incident hypertension: The Whitehall II Study. Hypertension 2007, 50:693 PMID: https://www.ncbi.nlm.nih.gov/pubmed/17785629
  50. 50.0 50.1 Knutson KL et al Association Between Sleep and Blood Pressure in Midlife The CARDIA Sleep Study Arch Intern Med. 2009;169(11):1055-1061 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19506175
  51. 51.0 51.1 O'Connor GT et al Prospective study of sleep-disordered breathing and hypertension: The Sleep Heart Health Study. Am J Respir Crit Care Med 2009, 179:1159 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19264976
  52. 52.0 52.1 Diao D et al Pharmacotherapy for mild hypertension (Review) The Cochrane Library, 2012, issue 8 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22895954 <Internet> http://www.thecochranelibrary.com/details/file/2486291/CD006742.html
    National Institutes of Health National Heart, Lung, and Blood Institute The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure NIH Publication No. 04-5230, August 2004 http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pdf
  53. 53.0 53.1 Weber MA et al Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. The Lancet, Early Online Publication, 6 December 2012 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23219284 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)61343-9/abstract
  54. 54.0 54.1 Hajjar I et al Effect of antihypertensive therapy on cognitive function in early executive cognitive impairment: a double-blind randomized clinical trial. Arch Intern Med. 2012 Mar 12;172(5):442-4 PMID: https://www.ncbi.nlm.nih.gov/pubmed/22412114
  55. 55.0 55.1 Delgado J, Jacobs EA, Lackland DT, et al. Differences in blood pressure control in a large population- based sample of older African Americans and non-Hispanic whites. J Gerontol A Biol Sci Med Sci. 2012 Nov;67(11):1253-8 PMID: https://www.ncbi.nlm.nih.gov/pubmed/22496537
  56. Choi HK, Soriano LC, Zhang Y, Rodriguez LA. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ 2012; 344:d8190 PMID: https://www.ncbi.nlm.nih.gov/pubmed/2224011
  57. 57.0 57.1 57.2 Ogawa H et al. Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients. Am J Med 2012 Oct; 125:981. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22503610
    Kim-Mitsuyama S et al. An angiotensin II receptor blocker-calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blocker alone. Kidney Int 2013 Jan; 83:167. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23051740
  58. 58.0 58.1 Weber MA et al. Effects of body size and hypertension treatments on cardiovascular event rates: Subanalysis of the ACCOMPLISH randomised controlled trial. Lancet 2013 Feb 16; 381:537 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23219284
    Messerli FH and Bangalore S. Diuretic-based regimens for obese patients? Lancet 2013 Feb 16; 381:512. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23219285
  59. Prescriber's Letter 20(4): 2013 Evidence-Based Strategies for Managing Hypertension and Dyslipidemia. Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=290421&pb=PRL (subscription needed) http://www.prescribersletter.com
  60. 60.0 60.1 Aburto NJ et al. Effect of increased potassium intake on cardiovascular risk factors and disease: Systematic review and meta-analyses. BMJ 2013 Apr 4; 346:f1378. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23558164
  61. Rosendorff C, Black HR, Cannon CP et al Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation. 2007 May 29;115(21):2761-88 PMID: https://www.ncbi.nlm.nih.gov/pubmed/17502569
  62. American College of Physicians. In the clinic. Hypertension. Ann Intern Med. 2008 Dec 2;149(11):ITC6(1-15). PMID: https://www.ncbi.nlm.nih.gov/pubmed/19047024
  63. Sarafidis PA, Bakris GL. Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol. 2008 Nov 25;52(22):1749-57. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19022154
  64. 64.0 64.1 McKinstry B et al. Telemonitoring based service redesign for the management of uncontrolled hypertension: Multicentre randomised controlled trial. BMJ 2013 May 24; 346:f3030 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23709583
  65. Ernst ME, Gordon JA. Diuretic therapy: key aspects in hypertension and renal disease. J Nephrol. 2010 Sep-Oct;23(5):487-93. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20677164
  66. 66.0 66.1 Flack JM, Sica DA, Bakris G, Brown AL et al Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 2010 Nov;56(5):780-800 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20921433
  67. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010 May 26;303(20):2043-50. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20501926
  68. 68.0 68.1 Bakris GL, Sarafidis PA, Weir MR et al Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Lancet. 2010 Apr 3;375(9721):1173-81. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20170948
  69. 69.0 69.1 Herttua K et al Adherence to antihypertensive therapy prior to the first presentation of stroke in hypertensive adults: population- based study. Eur Heart J. July 16, 2013 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23861328 <Internet> http://eurheartj.oxfordjournals.org/content/early/2013/07/09/eurheartj.eht219.abstract
  70. Mancia G et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013 Jun 14 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23771844 <Internet> http://eurheartj.oxfordjournals.org/content/34/28/2159
  71. 71.0 71.1 71.2 Jaffe MG et al Improved Blood Pressure Control Associated With a Large-Scale Hypertension Program. JAMA. 2013;310(7):699-705 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23989679 <Internet> http://jama.jamanetwork.com/article.aspx?articleid=1730511
    Goyal A and Bornstein WA Health System - Wide Quality Programs to Improve Blood Pressure Control. JAMA. 2013;310(7):695-696 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23989806 <Internet> http://jama.jamanetwork.com/article.aspx?articleid=1730495
  72. 72.0 72.1 72.2 72.3 Sabayan B et al. Association of visit-to-visit variability in blood pressure with cognitive function in old age: Prospective cohort study. BMJ 2013 Jul 30; 347:f4600 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23900315 <Internet> http://www.bmj.com/content/347/bmj.f4600?ijkey=0bd340e53dee6e98694626975fbf9f474815ce8a&keytype2=tf_ipsecsha
    Webb AJS Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. The Lancet. 2010 375:906-915 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/20226989 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)60235-8/fulltext
  73. 73.0 73.1 Go AS et al An effective Approach to High Blood Pressure Control A Science Advisory From the American Heart Association, the American College of Cardiology and the Centers for Disease Control and Prevention. Hypertension. Nov 15, 2013 http://hyper.ahajournals.org/content/early/2013/11/14/HYP.0000000000000003
  74. 74.0 74.1 74.2 74.3 74.4 Medscape: Dec 18, 2013 JNC 8 at Last! Guidelines Ease Up on BP Thresholds, Drug Choices. http://www.medscape.com/viewarticle/817991
    James PA et al 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults. Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA. Published online December 18, 2013 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24352797 <Internet> http://jama.jamanetwork.com/article.aspx?articleid=1791497
    Bauchner H et al Updated Guidelines for Management of High Blood Pressure Recommendations, Review, and Responsibility. JAMA. Published online December 18, 2013. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24352759 <Internet> http://jama.jamanetwork.com/article.aspx?articleid=1791423
    Peterson ED et al Recommendations for Treating Hypertension. What Are the Right Goals and Purposes? JAMA. Published online December 18, 2013. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24352710 <Internet> http://jama.jamanetwork.com/article.aspx?articleid=1791422
    Sox HC Assessing the Trustworthiness of the Guideline for Management of High Blood Pressure in Adults. JAMA. Published online December 18, 2013. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24352688 <Internet> http://jama.jamanetwork.com/article.aspx?articleid=1791421
  75. 75.0 75.1 Greenhalgh J, Dickson R, Dundar Y. Biofeedback for hypertension: a systematic review. J Hypertens. 2010 Apr;28(4):644-52. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20090554
  76. Prescriber's Letter 21(3): 2014 Treatment of Hypertension: JNC 8 and More Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=300317&pb=PRL (subscription needed) http://www.prescribersletter.com
  77. Ritchie LD, Campbell NC, Murchie P. New NICE guidelines for hypertension. BMJ. 2011 Sep 7;343:d5644. doi:http://dx.doi.org/ 10.1136/bmj.d5644. PMID: https://www.ncbi.nlm.nih.gov/pubmed/21900351
  78. 78.0 78.1 Kohler S et al. Temporal evolution of cognitive changes in incident hypertension: Prospective cohort study across the adult age span. Hypertension 2014 Feb; 63:245 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24296281 <Internet> http://hyper.ahajournals.org/content/63/2/245
  79. 79.0 79.1 Khalesi S et al Effect of Probiotics on Blood Pressure. A Systematic Review and Meta-Analysis of Randomized, Controlled Trials. Hypertension. July 21, 2014 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25047574 <Internet> http://hyper.ahajournals.org/content/early/2014/07/21/HYPERTENSIONAHA.114.03469
  80. 80.0 80.1 The Blood Pressure Lowering Treatment Trialists' Collaboration Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. The Lancet, 384(9943): 591-598, 16 August 2014 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25131978 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2961212-5/abstract
  81. 81.0 81.1 McManus RJ et al Effect of Self-monitoring and Medication Self-titration on Systolic Blood Pressure in Hypertensive Patients at High Risk of Cardiovascular DiseaseThe TASMIN-SR Randomized Clinical Trial. JAMA. 2014;312(8):799-808 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25157723 <Internet> http://jama.jamanetwork.com/article.aspx?articleid=1899205
    Nilsson PM and Nystrom FH Self-titration of Antihypertensive Therapy in High-Risk Patients. Bringing It Home. JAMA. 2014;312(8):795-796 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25157721 <Internet> http://jama.jamanetwork.com/article.aspx?articleid=1899182
  82. 82.0 82.1 Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: A meta-analysis of randomised trials. Lancet 2014 Nov 4; <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25468168 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2961171-5/fulltext
    Franklin SS and Weber MA. Optimum antihypertensive therapy: Does adiposity matter? Lancet 2014 Nov 4; <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25468165 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2961336-2/fulltext
  83. 83.0 83.1 Borden WB et al. Impact of the 2014 expert panel recommendations for management of high blood pressure on contemporary cardiovascular practice: Insights from the National Cardiovascular Data Registry PINNACLE Registry. J Am Coll Cardiol 2014 Nov 19 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25447261 <Internet> http://www.sciencedirect.com/science/article/pii/S0735109714063311
  84. 84.0 84.1 Sundstrom J et al Effects of Blood Pressure Reduction in Mild Hypertension: A Systematic Review and Meta-analysis. Ann Intern Med. Published online 23 December 2014 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25531552 <Internet> http://annals.org/article.aspx?articleid=2085847
  85. 85.0 85.1 85.2 85.3 85.4 Rosendorff C et al Treatment of Hypertension in Patients With Coronary Artery Disease. A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension. Hypertension. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25840695 <Internet> http://hyper.ahajournals.org/content/early/2015/03/30/HYP.0000000000000018
  86. 86.0 86.1 86.2 The NNT: Anti-Hypertensive Treatment for the Primary Prevention of Cardiovascular Events In Mild Hypertension. http://www.thennt.com/nnt/anti-hypertensives-for-cardiovascular-prevention-in-mild-hypertension/
  87. 87.0 87.1 The NNT: Blood Pressure Medicines for Five Years to Prevent Death, Heart Attacks, and Strokes. http://www.thennt.com/nnt/anti-hypertensives-to-prevent-death-heart-attacks-and-strokes/
  88. 88.0 88.1 88.2 88.3 88.4 88.5 Rosendorff C et al. Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. J Am Coll Cardiol 2015 May 12; 65:1998 PMID: https://www.ncbi.nlm.nih.gov/pubmed/25840655
  89. 89.0 89.1 Orciari Herman A, Fairchild DG, Hefner JE Blood Pressure Variability Tied to Increased Risk for CVD, Mortality. Physician's First Watch, July 28, 2015 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
    Muntner P et al. Visit-to-visit variability of blood pressure and coronary heart disease, stroke, heart failure, and mortality: A cohort study. Ann Intern Med 2015 Jul 28 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26215765 <Internet> http://annals.org/article.aspx?articleid=2398909
  90. 90.0 90.1 NIH News and Events. Sept 11, 2015 Landmark NIH study shows intensive blood pressure management may save lives. http://www.nih.gov/news/health/sep2015/nhlbi-11.htm
    Xie X, Atkins E, Lv J et al Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26559744 Lancet. Nov 7, 2015 http://thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2900805-3/abstract
    Brunstrom M, Carlberg B Lower blood pressure targets: to whom do they apply? Lancet. Nov 7, 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26559745d <Internet> http://thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2900816-8/abstract
    The Sprint Research Group A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. Nov 9, 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26551272 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1511939
    Drazen JM, Morrissey S, Campion EW, Jarcho JA. A SPRINT to the Finish. N Engl J Med. Nov 9, 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26551058 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMe1513991
    Perkovic V, Rodgers A Redefining Blood-Pressure Targets - SPRINT Starts the Marathon. N Engl J Med. Nov 9, 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26551394 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMe1513301
    Chobanian AV Time to Reassess Blood-Pressure Goals. N Engl J Med. November 9, 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26550920 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMp1513290
    Bress AP, Tanner RM, Hess R et al Generalizability of results from the Systolic Blood Pressure Intervention Trial (SPRINT) to the US adult population. J Am Coll Cardiol. 2015;() PMID: https://www.ncbi.nlm.nih.gov/pubmed/26562046 https://mail.google.com/mail/u/0/?tab=wm#inbox/150edbd5376db391
  91. 91.0 91.1 91.2 91.3 91.4 91.5 91.6 Hermida RC et al Sleep-time BP: prognostic marker of type 2 diabetes and therapeutic target for prevention. Diabetologia. First online: 23 September 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26399403 <Internet> http://link.springer.com/article/10.1007/s00125-015-3748-8
    Hermida RC et al Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial. Diabetologia. First online: 23 September 2015. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26399404 <Internet> http://link.springer.com/article/10.1007/s00125-015-3749-7
  92. 92.0 92.1 Ingelsson E, Bjorklund-Bodegard K, Lind L, Arnlov J, Sundstrom J. Diurnal blood pressure pattern and risk of congestive heart failure. JAMA. 2006 Jun 28;295(24):2859-66. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16804152
  93. 93.0 93.1 93.2 Emdin CA et al. Usual blood pressure, peripheral arterial disease, and vascular risk: Cohort study of 4.2 million adults. BMJ 2015 Sep 29; 351:h4865 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26419648 <Internet> http://www.bmj.com/content/351/bmj.h4865
  94. 94.0 94.1 94.2 94.3 Ettehad D, Emdin CA, Kiran A et al Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. Dec 23, 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26724178 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2901225-8/abstract
    Laurente S. Boutouyrie P Blood pressure lowering trials: wrapping up the topic? Lancet. Dec 23, 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26724177 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2901344-6/abstract
  95. Young K, Sadoughi S, Saitz R Antihypertensives in Diabetes Patients with BPs <140 Tied to Higher CV Mortality. Physician's First Watch, Feb 25, 2016 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
    Brunstrom M, Carlberg B Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ 2016;352:i717 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26920333 Free full text <Internet> http://www.bmj.com/content/352/bmj.i717
  96. Mancia G, De Backer G, Dominiczak A et al 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007 Jun;25(6):1105-87. PMID: https://www.ncbi.nlm.nih.gov/pubmed/17563527
  97. 97.0 97.1 97.2 Hermida RC, Ayala DE, Mojon A, Fernandez JR. Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J Am Soc Nephrol. 2011 Dec;22(12):2313-21. Epub 2011 Oct 24. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22025630 Free PMC Article
    Hermida RC, Crespo JJ, Dominguez-Sardina M et al. Bedtime hypertension treatment improves cardiovascular risk reduction: The Hygia Chronotherapy Trial. Eur Heart J 2019 Oct 22; ehz754 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31641769 https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehz754/5602478
    Mackenzie IS et al. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): A prospective, randomised, open-label, blinded-endpoint clinical trial. Lancet 2022 Oct 22; 400:1417. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36240838 Free article https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)01786-X/fulltext
  98. Sudano I, Flammer AJ, Roas S et al Nonsteroidal antiinflammatory drugs, acetaminophen, and hypertension. Curr Hypertens Rep. 2012 Aug;14(4):304-9. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22610476
  99. 99.0 99.1 99.2 Kario K, Saito I, Kushiro T et al Morning Home Blood Pressure Is a Strong Predictor of Coronary Artery Disease: The HONEST Study. J Am Coll Cardiol. 2016 Apr 5;67(13):1519-27. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27150682 Free Article
  100. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering treatment in hypertension: 8. Outcome reductions vs. discontinuations because of adverse drug events - meta-analyses of randomized trials. J Hypertens. 2016 Aug;34(8):1451-63. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27228434
    Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials. J Hypertens. 2016 Apr;34(4):613-22. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26848994
    Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure--meta-analyses of randomized trials. J Hypertens. 2016 Mar;34(3):373-84; discussion 384. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26780184
    Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs - overview and meta-analyses. J Hypertens. 2015 Jul;33(7):1321-41. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26039526
    Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses. J Hypertens. 2015 Feb;33(2):195-211. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25485720
    Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk--overview and meta-analyses of randomized trials. J Hypertens. 2014 Dec;32(12):2305-14. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25259548
    Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels--overview and meta-analyses of randomized trials. J Hypertens. 2014 Dec;32(12):2296-304. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25259547
    Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta- regression analyses of randomized trials. J Hypertens. 2014 Dec;32(12):2285-95. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25255397
  101. Chowdhury R, Khan H, Heydon E et al Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013 Oct;34(38):2940-8. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23907142 Free Article
  102. 102.0 102.1 Ritchey M, Chang A, Powers C, et al. Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries. United States, 2014. MMWR Morb Mortal Wkly Rep. ePub: 13 September 2016 https://www.cdc.gov/mmwr/volumes/65/wr/mm6536e1.htm
  103. 103.0 103.1 Lande MB, Batisky DL, Kupferman JC et al Neurocognitive Function in Children with Primary Hypertension. J Pediatr. 2016 Sep 27 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27692987 <Internet> http://www.jpeds.com/article/S0022-3476(16)30859-9/fulltext
  104. 104.0 104.1 Levine DL Diet Rich in Whole Grain May Cut Diastolic BP in Heavy Adults. Medscape. Oct 31, 2016 http://www.medscape.com/viewarticle/871105
  105. 105.0 105.1 Puttnam R, Davis BR, Pressel SL Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults. Secondary Analysis of a Randomized Clinical Trial. JAMA Intern Med. Published online November 21, 2016 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27893045 <Internet> http://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2587085
    Colon-Emeric CS, Lee R Cardiovascular Medications and Fractures. Dodging Complexity. JAMA Intern Med. Published online November 21, 2016. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27893011 <Internet> http://annals.org/aim/article/2588175/targeting-functional-decline-alzheimer-disease-randomized-trial
  106. Navar AM, Pencina MJ, Peterson ED Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and Treatment. JAMA Cardiol. 2016;1(8):864-871 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27604060 <Internet> http://jamanetwork.com/journals/jamacardiology/article-abstract/2549971
  107. 107.0 107.1 107.2 Bavishi C, Bangalore S, Messerli FH Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients. J Am Coll Cardiol 69(5): Feb 2017 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28153104 <Internet> http://www.onlinejacc.org/content/69/5/486
  108. 108.0 108.1 Qaseem A, Wilt TJ, Rich R et al. Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: A clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 2017 Jan 17; PMID: https://www.ncbi.nlm.nih.gov/pubmed/281357
    Weiss J, Freeman M, Low A et al. Benefits and harms of intensive blood pressure treatment in adults aged 60 years or older: A systematic review and meta- analysis. Ann Intern Med 2017 Jan 17; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28114673
    Pignone M, Viera AJ. Blood pressure treatment targets in adults aged 60 years or older. Ann Intern Med 2017 Jan 17; PMID: https://www.ncbi.nlm.nih.gov/pubmed/28114514
  109. 109.0 109.1 Bohm M et al. Achieved blood pressure and cardiovascular outcomes in high- risk patients: Results from ONTARGET and TRANSCEND trials. Lancet 2017 Apr 5 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28390695 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)30754-7/fulltext
  110. 110.0 110.1 Gupta P, Patel P, Strauch B et al. Risk factors for nonadherence to antihypertensive treatment. Hypertension 2017 Jun; 69:1113-1120. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28461599
    Hyman DJ. Hypertension: Does polypharmacy lead to nonadherence or nonadherence to polypharmacy? Hypertension 2017 Jun; 69:1017 PMID: https://www.ncbi.nlm.nih.gov/pubmed/28461603
  111. 111.0 111.1 Bennett A, Chow CK, Chou M et al Efficacy and Safety of Quarter-Dose Blood Pressure-Lowering Agents. A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Hypertension. June 5, 2017 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28584013 <Internet> http://hyper.ahajournals.org/content/early/2017/06/05/HYPERTENSIONAHA.117.09202
    Grassi G, Mancia G. Quarter Dose Combination Therapy. Good News for Blood Pressure Control Hypertension. June 5, 2017 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28584017 <Internet> http://hyper.ahajournals.org/content/early/2017/06/05/HYPERTENSIONAHA.117.09352
  112. 112.0 112.1 112.2 Niiranen TJ et al. Heritability and risks associated with early onset hypertension: Multigenerational, prospective analysis in the Framingham Heart Study. BMJ 2017;357:j1949 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28500036 Free PMC Article <Internet> http://www.bmj.com/content/357/bmj.j1949
  113. 113.0 113.1 113.2 113.3 Brunstrom M, Carlberg B Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels. A Systematic Review and Meta-analysis. JAMA Intern Med. Published online November 13, 2017 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29131895 https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2663255
  114. 114.0 114.1 Whelton PK, Carey RM, Aronow WS et al 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017. Nov 3, 2017 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29133356 <Internet> http://hyper.ahajournals.org/content/early/2017/11/10/HYP.0000000000000065
    Whelton PK, Carey RM, Aronow WS et al 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Hypertension. 2017. Nov 3, 2017 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29133354 <Internet> http://hyper.ahajournals.org/content/early/2017/11/10/HYP.0000000000000066
    Muntner P, Carey RM, Gidding S Potential U.S. Population Impact of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline. Circulation. 2017 Nov 13 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29133599 J Am Coll Cardiol. 2017 Nov 6. pii: S0735-1097(17)41474-4. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29146532 <Internet> http://www.onlinejacc.org/content/early/2017/11/01/j.jacc.2017.10.073
    Cifu AS, Davis AM Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. JAMA. Published online November 20, 2017. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29159416 https://jamanetwork.com/journals/jama/fullarticle/2664350
    Whelton PK, Carey RM The 2017 Clinical Practice Guideline for High Blood Pressure. JAMA. Published online November 20, 2017. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29159375 https://jamanetwork.com/journals/jama/fullarticle/2664351
  115. Cifu AS, Davis AM Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. JAMA. 2017;318(21):2132-2134 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29159416 https://jamanetwork.com/journals/jama/fullarticle/2664350
    Whelton PK, Carey RM The 2017 Clinical Practice Guideline for High Blood Pressure. JAMA. 2017;318(21):2073-2074. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29159375 https://jamanetwork.com/journals/jama/fullarticle/2664351
  116. 116.0 116.1 116.2 Tucker ME ADA 2018 Standards Address Diabetes Drugs With CV Benefit. Medscape. Dec 08, 2017. https://www.medscape.com/viewarticle/889800
    American Diabetes Association Introduction: Standards of Medical Care in Diabetes - 2018. Diabetes Care 2018 Jan; 41(Supplement 1): S1-S2 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29222369 <Internet> http://care.diabetesjournals.org/content/41/Supplement_1/S1
  117. Ioannidis JPA. Diagnosis and Treatment of Hypertension in the 2017 ACC/AHA Guidelines and in the Real World. JAMA. Published online December 14, 2017 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29242891 https://jamanetwork.com/journals/jama/fullarticle/2666624
    Greenland P. Cardiovascular Guideline Skepticism vs Lifestyle Realism? JAMA. Published online December 14, 2017 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29242938 https://jamanetwork.com/journals/jama/fullarticle/2666625
  118. 118.0 118.1 Frellick M. AAFP Declines to Endorse New 130/80 BP Treatment Guidelines. Medscape. Dec 15, 2017. https://www.medscape.com/viewarticle/890170
  119. Ioannidis JPA Diagnosis and Treatment of Hypertension in the 2017 ACC/AHA Guidelines and in the Real World. JAMA. 2018;319(2):115-116 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29242891 https://jamanetwork.com/journals/jama/article-abstract/2666624
  120. 120.0 120.1 120.2 Mills KT, Obst KM, Shen W et al. Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients: A systematic review and meta-analysis. Ann Intern Med 2017 Dec 26; [e-pub]. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29277852 <Internet> http://annals.org/aim/article-abstract/2667088/comparative-effectiveness-implementation-strategies-blood-pressure-control-hypertensive-patients-systematic
    Glynn LG, McManus RJ. Blood pressure control: Missed opportunity or potential holy grail? Ann Intern Med 2017 Dec 26; <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29277851 <Internet> http://annals.org/aim/article-abstract/2667090/blood-pressure-control-missed-opportunity-potential-holy-grail?doi=10.7326%2fM17-3036
  121. 121.0 121.1 Bakris G, Sorrentino M Redefining Hypertension - Assessing the New Blood-Pressure Guidelines. N Engl J Med. Jan 18, 2018 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29341841 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMp1716193?query=pfw&jwd=000000793830&jspc=FPG
  122. Wong A, Figueroa A, Son WM, Chernykh K, Park SW. The effects of stair climbing on arterial stiffness, blood pressure, and leg strength in postmenopausal women with stage 2 hypertension. Menopause. Feb 12, 2018 https://insights.ovid.com/crossref?an=00042192-900000000-97614
  123. 123.0 123.1 Taler SJ Initial Treatment of Hypertension. N Engl J Med 2018; 378:636-644 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29443671 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMcp1613481
  124. 124.0 124.1 Niiranen TJ, Henglin M, Claggett B et al Trajectories of Blood Pressure Elevation Preceding Hypertension Onset. An Analysis of the Framingham Heart Study Original Cohort. JAMA Cardiol. Published online March 21, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29562081 https://jamanetwork.com/journals/jamacardiology/fullarticle/2675360
  125. 125.0 125.1 Victor RG, Lynch K, Li N. A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops. N Engl J Med 2018; 378:1291-1301. April 5, 2018 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29527973 Free full text <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1717250
  126. 126.0 126.1 Brooks M Noisy Workplace Linked to Hypertension, Hyperlipidemia. Medscape. Apr 05, 2018. https://www.medscape.com/viewarticle/894831
    Kerns E, Masterson EA, Themann CL, Calvert GM. Cardiovascular conditions, hearing difficulty, and occupational noise exposure within US industries and occupations. Am J Ind Med. 2018 Mar 14 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29537072 https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajim.22833
  127. Rothaus C Initial Treatment of Hypertension NEJM Resident 360. Feb 14, 2018 https://resident360.nejm.org/content_items/initial-treatment-of-hypertension
  128. 128.0 128.1 McManus RJ, Mant J, Franssen M et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): An unmasked randomised controlled trial. Lancet 2018 Mar 10; 391:949. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29499873 Free PMC Article <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30309-X/fulltext
    Rietzschel ER, De Buyzere ML. Hypertension: Time for doctors to switch the driver's seat? Lancet 2018 Mar 10; 391:914. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29499874 Free Article <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30317-9/fulltext
  129. Bell KJL, Doust J, Glasziou P. Incremental Benefits and Harms of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline. JAMA Intern Med. Published online April 16, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29710197 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2678449
  130. 130.0 130.1 130.2 Banegas JR, Ruilope LM, de la Sierra A et al Relationship between Clinic and Ambulatory Blood-Pressure Measurements and Mortality. N Engl J Med 2018; 378:1509-1520. April 19. 2018 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29669232 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1712231
    Townsend RR The Value in an Ambulatory Blood-Pressure Registry. N Engl J Med 2018; 378:1555-1556. April 19, 2018 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29669227 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMe1802369
  131. 131.0 131.1 Bundy JD, Mills KT, Chen J et al Estimating the Association of the 2017 and 2014 Hypertension Guidelines With Cardiovascular Events and Deaths in US Adults. An Analysis of National Data. JAMA Cardiol. Published online May 23, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29800138 https://jamanetwork.com/journals/jamacardiology/fullarticle/2681851
    Fine LJ, Goff DC, Mensah GA Blood Pressure Control - Much Has Been Achieved, Much Remains to Be Done. JAMA Cardiol. Published online May 23, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29800015 https://jamanetwork.com/journals/jamacardiology/fullarticle/2681845
    Yancy CW, Fonarow GC. The New Hypertension Guidelines. Compelling Population Benefit, Manageable Risk, and Time to Implement. JAMA Cardiol. Published online May 23, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29800020 https://jamanetwork.com/journals/jamacardiology/fullarticle/2681846
  132. 132.0 132.1 132.2 Khera R, Lu Y, Lu J et al Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study. BMJ 2018;362:k2357 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29997129 https://www.bmj.com/content/362/bmj.k2357
  133. Jackson SL, Zhang Z, Wiltz JL, et al. Hypertension Among Youths - United States, 2001-2016. MMWR Morb Mortal Wkly Rep 2018;67:758-762 https://www.cdc.gov/mmwr/volumes/67/wr/mm6727a2.htm
  134. 134.0 134.1 Sheppard JP et al. Prospective external validation of the Predicting Out-of-Office Blood Pressure (PROOF-BP) strategy for triaging ambulatory monitoring in the diagnosis and management of hypertension: Observational cohort study. BMJ 2018 Jun 27; 361:k2478 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29950396 Free PMC Article https://www.bmj.com/content/361/bmj.k2478
  135. 135.0 135.1 Webster R, Salam A, de Silva A et al Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka. A Randomized Clinical Trial. JAMA. 2018;320(6):566-579. PMID: https://www.ncbi.nlm.nih.gov/pubmed/30120478 https://jamanetwork.com/journals/jama/fullarticle/2697010
    Huffman MD,Ogedegbe G, Jaffe M Low-Dose Combination Blood Pressure Pharmacotherapy to Improve Treatment Effectiveness, Safety, and Efficiency. JAMA. 2018;320(6):552-554 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30120460 https://jamanetwork.com/journals/jama/fullarticle/2696988
  136. 136.0 136.1 Hinderliter A et al P388 / P388 - Lifestyle Interventions Reduce the Need for Guideline-Directed Antihypertensive Medication. AHA/ASA 2018 https://www.abstractsonline.com/pp8/#!/4687/presentation/3369
    Lifestyle changes reduce the need for blood pressure medications American Heart Association Meeting Report - Presentation P388 September 08, 2018 https://newsroom.heart.org/news/lifestyle-changes-reduce-the-need-for-blood-pressure-medications
  137. 137.0 137.1 Markovitz AA, Mack JA, Nallamothu BK, Ayanian JZ, Ryan AM. Incremental effects of antihypertensive drugs: Instrumental variable analysis. BMJ 2017 Dec 22; 359:j5542 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29273586 Free PMC Article <Internet> http://www.bmj.com/content/359/bmj.j5542
  138. 138.0 138.1 Howard G, Cushman M, Moy CS et al Association of Clinical and Social Factors With Excess Hypertension Risk in Black Compared With White US Adults. JAMA. 2018;320(13):1338-1348 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30285178 https://jamanetwork.com/journals/jama/fullarticle/2705187
  139. 139.0 139.1 139.2 Sheppard JP, Stevens S, Stevens R et al Benefits and Harms of Antihypertensive Treatment in Low-Risk Patients With Mild Hypertension. JAMA Intern Med. Published online October 29, 2018. PMID: https://www.ncbi.nlm.nih.gov/pubmed/30383082 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2708195
  140. 140.0 140.1 Yano Y, Reis JP, Colangelo LA et al Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life. JAMA. 2018;320(17):1774-1782 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30398601 https://jamanetwork.com/journals/jama/fullarticle/2712542
    Son JS, Choi S, Kim K et al Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/ American Heart Association Guidelines With Subsequent Cardiovascular Disease Events. JAMA. 2018;320(17):1783-1792 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30398603 https://jamanetwork.com/journals/jama/fullarticle/2712544
    Vasan RS High Blood Pressure in Young Adulthood and Risk of Premature Cardiovascular Disease. Calibrating Treatment Benefits to Potential Harm. JAMA. 2018;320(17):1760-1763 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30398583 https://jamanetwork.com/journals/jama/fullarticle/2712523
    Fisher NDL, Curfman G Hypertension - A Public Health Challenge of Global Proportions. JAMA. 2018;320(17):1757-1759. PMID: https://www.ncbi.nlm.nih.gov/pubmed/30398584 https://jamanetwork.com/journals/jama/fullarticle/2712524
  141. 141.0 141.1 Victor RG, Blyler CA, Li N, Lynch K et al. Sustainability of blood pressure reduction in black barbershops. Circulation. 2019 Jan 2;139(1):10-19. Online Dec 17, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30592662 https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.038165
  142. Rosendorff C, Lackland DT, Allison M et al Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Circulation. 2015 May 12;131(19):e435-70. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25829340
  143. Weir MR. In the clinic: hypertension. Ann Intern Med. 2014 Dec 2;161(11):ITC1-15; Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25437425
  144. 144.0 144.1 Ojji DB, Mayosi B, Francis V et al. Comparison of dual therapies for lowering blood pressure in black Africans. N Engl J Med 2019 Mar 18; PMID: https://www.ncbi.nlm.nih.gov/pubmed/30883050
  145. 145.0 145.1 145.2 Flint AC, Conell C, Ren X Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes. N Engl J Med 2019; 381:243-251 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31314968 https://www.nejm.org/doi/full/10.1056/NEJMoa1803180
  146. 146.0 146.1 Herrett E, Gadd S, Jackson R et al. Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: A retrospective cohort study. Lancet 2019 Aug 24; 394:663. PMID: https://www.ncbi.nlm.nih.gov/pubmed/31353050 Free PMC Article https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)31359-5/fulltext
    Kahan T. Strategies to identify patients for antihypertensive treatment. Lancet 2019 Aug 24; 394:615. PMID: https://www.ncbi.nlm.nih.gov/pubmed/31353049 Free Article https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)31665-4/fulltext
  147. 147.0 147.1 Suchard MA, Schuemie MJ, Krumholz HM et al Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large- scale analysis. Lancet. Oct 24, 2019 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31668726 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32317-7/fulltext
    Ives CW Oparil S What is the first choice for blood pressure treatment? Lancet. Oct 24, 2019 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31668725 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32461-4/fulltext
  148. Anderson TS, Odden M, Penko J et al Generalizability of Clinical Trials Supporting the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline. JAMA Intern Med. Published online March 16, 2020 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32176252 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2762877
  149. 149.0 149.1 Wang N, Salam A, Webster R et al Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension. A Secondary Analysis of the TRIUMPH Trial. JAMA Cardiol. 2020;5(11):1219-1226 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32717045 PMCID: PMC7376473 Free PMC article https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2020.2739
  150. 150.0 150.1 McManus RJ, Little P, Stuart B et al. Home and online management and evaluation of blood pressure (HOME BP) using a digital intervention in poorly controlled hypertension: Randomised controlled trial. BMJ 2021 Jan 20; 372:m4858. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33468518 PMCID: PMC7814507 Free PMC article https://www.bmj.com/content/372/bmj.m4858
  151. Blood Pressure Lowering Treatment Trialists' Collaboration. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: An individual participant-level data meta-analysis. Lancet 2021 Aug 26; [e-pub]. https://linkinghub.elsevier.com/retrieve/pii/S0140673621019218
  152. 152.0 152.1 Chow CK, Atkins ER, Hillis GS et al. Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): A phase 3, randomised, double-blind, active-controlled trial. Lancet 2021 Sep 18; 398:1043. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01922-X/fulltext
  153. 153.0 153.1 Chen R, Suchard MA, Krumholz HM et al. Comparative first-line effectiveness and safety of ACE (angiotensin- converting enzyme) inhibitors and angiotensin receptor blockers: A multinational cohort study. Hypertension 2021 Sep; 78:591. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34304580 PMCID: PMC8363588 (available on 2022-09-01) https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.120.16667
  154. 154.0 154.1 Aubert CE, Sussman JB, Hofer TP et al. Adding a new medication versus maximizing dose to intensify hypertension treatment in older adults: A prospective observational study. Ann Intern Med 2021 Oct 5 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34606315 https://www.acpjournals.org/doi/10.7326/M21-1456
  155. 155.0 155.1 Bogaerts JMK, von Ballmoos LM, Achterberg WP et al Do we AGREE on the targets of antihypertensive drug treatment in older adults: a systematic review of guidelines on primary prevention of cardiovascular diseases. Age & Ageing, 2021. Oct 26 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34718378 https://academic.oup.com/ageing/advance-article/doi/10.1093/ageing/afab192/6410447
  156. 156.0 156.1 Margolis KL et al. Comparing pharmacist-led telehealth care and clinic-based care for uncontrolled high blood pressure: The Hyperlink 3 pragmatic cluster-randomized trial. Hypertension 2022 Dec; 79:2708. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36281763 PMCID: PMC9649877 (available on 2023-12-01) https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.122.19816
  157. 157.0 157.1 Zhang J, Mao Y, Li Y et al Association between migraine or severe headache and hypertension among US adults: A cross-sectional study. Nut Metab Cardiovasc Dis. 2022 Nov 18;S0939-4753(22)00457-4. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36604265
  158. Whelton PK, Carey RM, Aronow WS et al 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines J Am Coll Cardiol. 2018 May 15;71(19):e127-e248. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29146535 Free article
  159. 159.0 159.1 159.2 Ku E et al. Acute declines in estimated GFR in blood pressure target trials and risk of adverse outcomes. Am J Kidney Dis 2023 Oct; 82:454. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37269972 https://www.ajkd.org/article/S0272-6386(23)00653-4/fulltext
  160. 160.0 160.1 160.2 Juraschek SP, Hu JR, Cluett JL et al Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease. An Individual Participant Meta-Analysis. JAMA. 2023;330(15):1459-1471 PMID: https://www.ncbi.nlm.nih.gov/pubmed/37847274 https://jamanetwork.com/journals/jama/fullarticle/2810698
  161. 161.0 161.1 Varghese JS, Lu P, Choi D et al Spousal Concordance of Hypertension Among Middle-Aged and Older Heterosexual Couples Around the World: Evidence From Studies of Aging in the United States, England, China, and India. J Am Heart Assoc (JAHA): 2023, Dec 3 PMID: https://www.ncbi.nlm.nih.gov/pubmed/38054385 https://www.ahajournals.org/doi/10.1161/JAHA.123.030765
  162. 162.0 162.1 Yamal JM, Martinez J, Osani MC et al Mortality and Morbidity Among Individuals With Hypertension Receiving a Diuretic, ACE Inhibitor, or Calcium Channel Blocker. A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2023;6(12):e2344998. PMID: https://www.ncbi.nlm.nih.gov/pubmed/38048133 PMCID: PMC10696481 Free PMC article https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2812523

Patient information

chronic hypertension patient information